John C. Probasco

3.5k total citations
67 papers, 1.5k citations indexed

About

John C. Probasco is a scholar working on Neurology, Infectious Diseases and Epidemiology. According to data from OpenAlex, John C. Probasco has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 12 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in John C. Probasco's work include Autoimmune Neurological Disorders and Treatments (31 papers), Peripheral Neuropathies and Disorders (11 papers) and Infectious Encephalopathies and Encephalitis (10 papers). John C. Probasco is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (31 papers), Peripheral Neuropathies and Disorders (11 papers) and Infectious Encephalopathies and Encephalitis (10 papers). John C. Probasco collaborates with scholars based in United States, United Kingdom and Spain. John C. Probasco's co-authors include Arun Venkatesan, Lilja B. Sólnes, Mehrbod S. Javadi, Krystyna M. Jones, Jesse Cohen, Romergryko G. Geocadin, Douglas B. Johnson, Alexandra M. Haugh, Mackenzie C. Cervenka and Evan J. Lipson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Neurology.

In The Last Decade

John C. Probasco

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Probasco United States 19 779 361 287 271 202 67 1.5k
Daniela Pohl Canada 31 1.8k 2.3× 425 1.2× 232 0.8× 378 1.4× 84 0.4× 100 3.8k
Yann Mikaeloff France 26 978 1.3× 196 0.5× 323 1.1× 267 1.0× 60 0.3× 49 2.6k
Leif G. Hanitsch Germany 20 426 0.5× 140 0.4× 400 1.4× 246 0.9× 174 0.9× 49 2.0k
Katharina Fink Sweden 20 475 0.6× 482 1.3× 69 0.2× 160 0.6× 199 1.0× 65 2.1k
Ira Bergman United States 28 263 0.3× 178 0.5× 215 0.7× 289 1.1× 313 1.5× 59 1.9k
Karen Schreiber Denmark 29 358 0.5× 142 0.4× 89 0.3× 112 0.4× 115 0.6× 85 2.7k
Michael Nicolle Canada 24 2.2k 2.8× 173 0.5× 73 0.3× 137 0.5× 197 1.0× 58 3.1k
Raed Alroughani Kuwait 24 483 0.6× 335 0.9× 326 1.1× 98 0.4× 38 0.2× 166 2.2k
Mari Hagiwara United States 23 570 0.7× 108 0.3× 54 0.2× 402 1.5× 222 1.1× 73 1.8k
K. Patel United Kingdom 17 578 0.7× 211 0.6× 70 0.2× 104 0.4× 156 0.8× 37 1.2k

Countries citing papers authored by John C. Probasco

Since Specialization
Citations

This map shows the geographic impact of John C. Probasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Probasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Probasco more than expected).

Fields of papers citing papers by John C. Probasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Probasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Probasco. The network helps show where John C. Probasco may publish in the future.

Co-authorship network of co-authors of John C. Probasco

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Probasco. A scholar is included among the top collaborators of John C. Probasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Probasco. John C. Probasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quinn, Carson, Prashanth Rajarajan, Alexander J. Gill, et al.. (2024). Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Neurology. 103(11). e210003–e210003. 5 indexed citations
2.
Quinn, Carson, Prashanth Rajarajan, Andrew B. Wolf, et al.. (2024). Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications (PL4.004). Neurology. 102(7_supplement_1). 2 indexed citations
3.
Quinn, Carson, Prashanth Rajarajan, Andrew B. Wolf, et al.. (2024). Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors. Neurology. 103(7_Supplement_1).
4.
Probasco, John C., et al.. (2024). Development and Validation of a Risk Score for Predicting ICU Admission in Adults with New-Onset Encephalitis. Neurocritical Care. 42(1). 196–206. 2 indexed citations
5.
Husari, Khalil S., Lilja B. Sólnes, Mackenzie C. Cervenka, et al.. (2023). EEG Correlates of Qualitative Hypermetabolic FDG-PET in Patients With Neurologic Disorders. Neurology Clinical Practice. 13(2). e200135–e200135. 5 indexed citations
6.
Sadaghiani, Mohammad Salehi, et al.. (2023). Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis. Neuroradiology. 65(8). 1225–1238. 9 indexed citations
7.
Zeiger, William, Scott R. DeBoer, & John C. Probasco. (2020). Patterns and Perceptions of Smartphone Use Among Academic Neurologists in the United States: Questionnaire Survey. JMIR mhealth and uhealth. 8(12). e22792–e22792. 5 indexed citations
8.
Gugger, James J., Khalil S. Husari, John C. Probasco, & Mackenzie C. Cervenka. (2019). New-onset refractory status epilepticus: A retrospective cohort study. Seizure. 74. 41–48. 43 indexed citations
9.
Purvis, Taylor E., et al.. (2019). Staff Perceptions of Chaplains in a Neurosciences Critical Care Unit. Journal of Religion and Health. 58(6). 2086–2094. 8 indexed citations
10.
Yan, Haijuan, et al.. (2019). Prevalence and Improvement of Caine-Positive Wernicke-Korsakoff Syndrome in Psychiatric Inpatient Admissions. Psychosomatics. 61(1). 31–38. 9 indexed citations
11.
Fitzgerald, Kathryn C., et al.. (2019). The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse. Multiple Sclerosis and Related Disorders. 35. 61–66. 3 indexed citations
12.
Cohen, Jesse, Javier Sotoca, Anusha K. Yeshokumar, et al.. (2019). Autoimmune encephalitis. Neurology. 92(9). e964–e972. 47 indexed citations
13.
Venkatesan, Arun, Benedict Michael, John C. Probasco, Romergryko G. Geocadin, & Tom Solomon. (2019). Acute encephalitis in immunocompetent adults. The Lancet. 393(10172). 702–716. 86 indexed citations
15.
Abboud, Hesham, Ian Rossman, Maureen A. Mealy, et al.. (2017). Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results. Journal of Neurology. 264(11). 2284–2292. 20 indexed citations
16.
Sólnes, Lilja B., Krystyna M. Jones, Steven P. Rowe, et al.. (2017). Diagnostic Value of18F-FDG PET/CT Versus MRI in the Setting of Antibody-Specific Autoimmune Encephalitis. Journal of Nuclear Medicine. 58(8). 1307–1313. 99 indexed citations
17.
Yeshokumar, Anusha K., Eliza Gordon‐Lipkin, Jesse Cohen, et al.. (2017). Neurobehavioral outcomes in autoimmune encephalitis. Journal of Neuroimmunology. 312. 8–14. 52 indexed citations
18.
Thakur, Kiran T., John C. Probasco, Sara E. Hocker, et al.. (2014). Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 82(8). 665–670. 132 indexed citations
19.
Probasco, John C., et al.. (2013). Clinical Reasoning: Multiple cranial neuropathies in a young man. Neurology. 80(6). 3 indexed citations
20.
Probasco, John C., Steven G. Deeks, Evelyn Lee, et al.. (2010). Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS. 24(7). 1001–1005. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026